美股A股
StockGist
Back
8-K2026-05-15· grok-4-1-fast-non-reasoning

BREZ · Breeze Acquisition Corp. II

0001213900-26-057783

SEC filing

Summary

Breeze Acquisition Corp. II completed its IPO of 14,000,000 units at $10.00 each, raising $140M in net proceeds placed in trust, with related agreements executed and new directors appointed.

Key takeaways

Full analysis

Breeze Acquisition Corp. II, a Cayman Islands blank check company targeting healthcare, biotech, advanced manufacturing, robotics, and AI sectors, successfully closed its upsized IPO on May 14, 2026. The offering included 12.5 million firm units plus a partial exercise of the over-allotment option for 1.5 million additional units, totaling 14 million units sold at $10 each, generating $140 million in gross proceeds from the IPO and $4.7 million from the simultaneous private placement to sponsor Breeze Sponsor II, LLC. Net proceeds of $140.35 million were placed in a U.S. trust account maintained by Continental Stock Transfer & Trust Company, available for release upon business combination, shareholder redemption, or specific amendments within 12 months. Key agreements executed on May 12 include the underwriting agreement with IB Capital LLC, rights agreement, letter agreement with sponsor and insiders, trust agreement, registration rights, administrative services at $5,000/month, private placement purchase, and indemnity agreements for directors/officers. Four independent directors were appointed effective the registration statement date, forming fully independent audit (Rick Baldwin chair), compensation (Michael J. Pine chair), and nominating/governance (Anthony Przybyslawski chair) committees, enhancing governance for the SPAC's business combination pursuit. Amended governing documents became effective May 13. Units trade as BREZU on Nasdaq, with separate trading of shares (BREZ) and rights (BREZR) pending. This capital raise positions the company to pursue its initial business combination.